Combining CRISPR and DNA barcoding can track cancer growth

Stanford researchers say the combination of CRISPR-Cas9 and DNA barcoding could allow scientists to replicate the kind of genetic diversity observed in cancer patients. Credit: National Human Genome Research Institute.